Skip to content
Resources > Reports

Healthcare 2026 Industry Outlook: A Year of Necessary Transformation

By Sara Mallatt, Director of Healthcare Research

The global healthcare industry is at an inflection point, moving from a year of defensive maneuvering to one that requires strategic transformation. In 2025, healthcare companies were forced to react to many immediate, high-magnitude threats. The pressures of 2025 suggest that in 2026 the healthcare industry will need to shift toward structural changes that ensure long-term prosperity.

While 2025 was a period of diagnosis and defense, 2026 will likely be a year of execution and fundamental transformation as firms race to ensure long-term financial viability. Drawing on Tegus Expert Insights and other proprietary intelligence in AlphaSense, this report maps the critical path to that transformation.

About the Author
  • Sara Mallatt, Director of Healthcare Research

    Sara has more than 18 years of experience generating sell-side research content across a variety of industries. Prior to joining AlphaSense, Sara held leadership positions at OTR Global, a leading channel research firm, most recently as Director of Healthcare Research. Sara holds a bachelor’s degree in journalism and a master’s in industrial engineering. She works from her home in Missoula, Montana.

Explore more

The VC Playbook: How to Spot a Purple Cow in Crowded Pastures

In this playbook, we leverage insights from Harry Stebbings of 20VC to answer this question among others, including: What are the characteristics of successful early stage companies? Which unconventional criteria play an important role in securing deals?
Title slide for 'The Venture Capital Playbook: How to Spot a Purple Cow in Crowded Pastures,' featuring outlined illustrations of a purple cow and a white bull.

Execution in Focus: Tracking Key Healthcare and Biopharma Trends in 2026

This report tackles these issues and other key trends shaping the healthcare landscape in early 2026.
Title slide: Tracking Key Healthcare and Biopharma Trends in 2026 by Sara Mallatt and Sean Carmichael, featuring data graphs and medical icons.

Top AI Use Cases for Investment Banking

In this report, we explore how AI is transforming IB workflows by streamlining and accelerating intelligence and insights at scale.
Blue graphic for an article titled 'Top AI Use Cases For Investment Banking,' featuring white blueprint-style outlines of a skyscraper, dollar sign, and euro symbol on a grid.

Transform intelligence
into advantage

Develop bold strategies, seize opportunities,
and lead with clarity and confidence.